Adherence to clinical practice guidelines (CPGs) for the treatment of cancers in Australia and the factors associated with adherence: a systematic review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 09 2021
Historique:
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 3 11 2021
Statut: epublish

Résumé

Clinical practice guidelines (CPGs) synthesise the latest evidence to support clinical and patient decision-making. CPG adherent care is associated with improved patient survival outcomes; however, adherence rates are low across some cancer streams in Australia. Greater understanding of specific barriers to cancer treatment CPG adherence is warranted to inform future implementation strategies.This paper presents the protocol for a systematic review that aims to determine cancer treatment CPG adherence rates in Australia across a variety of common cancers, and to identify any factors associated with adherence to those CPGs, as well as any associations between CPG adherence and patient outcomes. Five databases will be searched, Ovid Medline, PsychInfo, Embase, Scopus and Web of Science, for eligible studies evaluating adherence rates to cancer treatment CPGs in Australia. A team of reviewers will screen the abstracts in pairs according to predetermined inclusion criteria and then review the full text of eligible studies. All included studies will be assessed for quality and risk of bias. Data will be extracted using a predefined data extraction template. The frequency or rate of adherence to CPGs, factors associated with adherence to those CPGs and any reported patient outcome rates (eg, relative risk ratios or 5-year survival rates) associated with adherence to CPGs will be described. If applicable, a pooled estimate of the rate of adherence will be calculated by conducting a random-effects meta-analysis. The systematic review will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Ethics approval will not be required, as this review will present anonymised data from other published studies. Results from this study will form part of a doctoral dissertation (MB), will be published in a journal, presented at conferences, and other academic presentations. CRD42020222962.

Identifiants

pubmed: 34548359
pii: bmjopen-2021-050912
doi: 10.1136/bmjopen-2021-050912
pmc: PMC8458325
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e050912

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Genitourin Cancer. 2018 Dec;16(6):e1159-e1169
pubmed: 30190222
BMC Cancer. 2015 Jul 11;15:515
pubmed: 26163015
Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):812-820
pubmed: 30861596
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Med J Aust. 2007 Mar 19;186(6):292-5
pubmed: 17371209
Asia Pac J Clin Oncol. 2017 Oct;13(5):e224-e231
pubmed: 26997361
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
J Oncol Pract. 2012 Jul;8(4):253-9
pubmed: 23180992
Clin Oncol (R Coll Radiol). 2016 Oct;28(10):639-47
pubmed: 27211609
Worldviews Evid Based Nurs. 2007;4(4):210-9
pubmed: 18076464
Cancer Treat Rev. 2015 Feb;41(2):197-215
pubmed: 25579752
ANZ J Surg. 2001 Mar;71(3):147-53
pubmed: 11277143
Radiother Oncol. 2019 Dec;141:41-47
pubmed: 31606225
Cancer. 2013 Apr 15;119(8):1593-601
pubmed: 23280510
Asia Pac J Clin Oncol. 2017 Oct;13(5):e373-e380
pubmed: 27726297
Gynecol Oncol. 2015 Jul;138(1):121-7
pubmed: 25913132
J Eval Clin Pract. 2018 Feb;24(1):135-144
pubmed: 28474459
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Breast. 2010 Oct;19(5):396-401
pubmed: 20452216
Ann Surg Oncol. 2017 Aug;24(8):2080-2088
pubmed: 28547563
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):748-757
pubmed: 28366580
Clin Breast Cancer. 2015 Aug;15(4):e189-95
pubmed: 25913904
Obstet Gynecol. 2015 Apr;125(4):833-842
pubmed: 25751200
Med Care. 2001 Aug;39(8 Suppl 2):II46-54
pubmed: 11583121
Implement Sci. 2014 Mar 22;9(1):36
pubmed: 24655753
Obstet Gynecol. 2013 Jun;121(6):1226-1234
pubmed: 23812456
Breast. 2003 Apr;12(2):136-41
pubmed: 14659343
JAMA. 1999 Oct 20;282(15):1458-65
pubmed: 10535437
BMJ Open. 2020 Mar 23;10(3):e035448
pubmed: 32205377
BMC Health Serv Res. 2013 Dec 21;13:530
pubmed: 24359085
J Clin Oncol. 2012 Mar 20;30(9):972-9
pubmed: 22355049
Ann Oncol. 2011 Apr;22(4):821-826
pubmed: 20929965
CMAJ. 2010 Feb 9;182(2):E78-84
pubmed: 19969563
Ann Oncol. 2013 Jun;24(6):1685-91
pubmed: 23446092
Am J Surg. 2006 Oct;192(4):525-7
pubmed: 16978966
Implement Sci. 2020 May 27;15(1):39
pubmed: 32460797

Auteurs

Mia Bierbaum (M)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia mia.bierbaum@hdr.mq.edu.au.

Frances Rapport (F)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Gaston Arnolda (G)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Yvonne Tran (Y)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Macquarie University Hearing, Sydney, New South Wales, Australia.

Bróna Nic Giolla Easpaig (B)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Kristiana Ludlow (K)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
The University of Queensland, School of Psychology, Saint Lucia, Queensland, Australia.

Jeffrey Braithwaite (J)

Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH